Zhongxun X. Shi

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Gut Microbiota Alterations in Myelodysplastic Neoplasms Are Associated With Immune Dysfunction and the Therapeutic Mechanism of Hypomethylating Agents.

Gut Microbiota Alterations in Myelodysplastic Neoplasms Are Associated With Immune Dysfunction and the Therapeutic Mechanism of Hypomethylating Agents.

Journal: Cancer medicine

Published: December 03, 2025

Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis.

Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis.

Journal: British journal of haematology

Published: August 08, 2025

The role of CD38 in monocytes during fibrotic progression of myeloproliferative neoplasms.

The role of CD38 in monocytes during fibrotic progression of myeloproliferative neoplasms.

Journal: Blood

Published: March 04, 2025

Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

Journal: British journal of haematology

Published: July 15, 2024

Loeys-Dietz syndrome with concomitant aplastic anemia.

Loeys-Dietz syndrome with concomitant aplastic anemia.

Journal: Annals of hematology

Published: August 07, 2023

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.

Journal: Haematologica

Published: November 07, 2021

Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.

Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.

Journal: Haematologica

Published: September 24, 2021

RBC distribution width predicts thrombosis risk in polycythemia vera.

RBC distribution width predicts thrombosis risk in polycythemia vera.

Journal: Leukemia

Published: July 07, 2021

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

Journal: Blood cancer journal

Published: July 02, 2021

Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations

Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: November 16, 2020

Identification and lineage restriction analyses of preleukemia cells in a sporadic biallelic CEBPA mutated acute myeloid leukemia patient.

Identification and lineage restriction analyses of preleukemia cells in a sporadic biallelic CEBPA mutated acute myeloid leukemia patient.

Journal: International journal of laboratory hematology

Published: July 17, 2020

Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts

Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: June 16, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026